Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|April 1, 2004
- Volume 0 0
Colace/Peri-Colace
Advertisement
Purdue Pharmaceutical Products' (Stamford, Conn) Colace/Peri-Colace laxatives are used to treat constipation. Colace's active ingredient is docusate sodium. Docusate sodium allows water and fats to get into the stool and helps to soften fecal material. Colace is available in capsules, syrup, liquid 1% solution, and glycerin suppositories. Peri-Colace's active ingredients are docusate sodium and standardized senna concentrate. These ingredients help relieve occasional constipation. Peri-Colace is available in tablets. For more information: www.peri-colace.com
Articles in this issue
over 22 years ago
RxPRODUCT NEWS PROFILE: Caduetover 22 years ago
COMPOUNDING HOTLINEover 22 years ago
Case Studiesover 22 years ago
Buddies Are Good for the Heartover 22 years ago
Low-Fat Diet Shows Promise for Prostate Cancerover 22 years ago
Rage Is Connected to Stroke Riskover 22 years ago
InnoLetover 22 years ago
TampAlerTover 22 years ago
Low Testosterone Is Linked with Alzheimer's Diseaseover 22 years ago
Wound Care in an Aging Population: Special ConsiderationsAdvertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
After 180 Years, Multiple Myeloma Gets a Definition of Cure
4
Not So Rare After All: Pharmacists Weigh In on Diagnosing and Managing ATTR-CM
5